SEAGULL HEALTH
Your health,We care!
Orelabrutinib can precisely inhibit the proliferation, survival and migration of malignant B cells, and is featured by strong targeting ability and favorable safety profile.
AuthenticGuaranteeFast DeliveryPrivacy Beijing, China, April 25, 2025 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed novel Bruton's···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 120
Beijing, China, April 20, 2023 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed novel Bruton's···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 125
Beijing, China – December 31, 2020 – InnoCare Pharma, a high-tech biopharmaceutical company, announced that its independently developed Bruton's t···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 102
Beijing, China, December 27, 2020 – InnoCare Pharma (Hong Kong Stock Exchange: 09969), a high-tech biopharmaceutical company, announced today that its···【Read More】
Update: 22 Jan,2026Source: Haiou HealthViews: 96
Copyright 2024 @ haiouhealth.com All right reserved SEAGULL HEALTH
